Rheumatoid Arthritis Medication for Elderly Parents — A Caregiver's Guide

Your mother's hands hurt. Not the dull ache of osteoarthritis that most people her age experience, but a swollen, hot, symmetrical pain in both wrists and knuckles that's worst in the morning and keeps her from opening a jar or buttoning a shirt. The rheumatologist diagnosed rheumatoid arthritis and started talking about methotrexate, biologics, and monthly blood tests. You nodded along, but you're now realizing this medication regimen is significantly more complex — and more dangerous — than anything else in her medicine cabinet.

Rheumatoid arthritis (RA) is an autoimmune disease where the immune system attacks the joints, causing inflammation, pain, and eventually joint destruction. Unlike osteoarthritis (which is wear-and-tear damage), RA requires medications that suppress the immune system. And immune-suppressing drugs in an elderly patient who already has age-related immune decline create a particular set of risks that caregivers need to understand and manage.

How RA treatment works

RA treatment follows a tiered approach, and most patients end up on a combination of medications:

NSAIDs and corticosteroids (symptom control)

These are used for quick relief but are not the core treatment. NSAIDs (ibuprofen, naproxen, celecoxib) reduce pain and inflammation. Corticosteroids (prednisone) are powerful anti-inflammatories used for flares. Both carry significant risks in elderly patients — NSAIDs affect the stomach, kidneys, and cardiovascular system, while long-term prednisone causes osteoporosis, diabetes, cataracts, and immune suppression.

DMARDs (Disease-Modifying Antirheumatic Drugs)

These are the backbone of RA treatment. They don't just reduce symptoms — they slow or stop the disease from destroying joints.

Methotrexate is the anchor drug for RA. It's been the standard first-line DMARD for decades, and for good reason — it's effective, well-studied, and inexpensive. However, methotrexate requires careful management:

• Taken once weekly, not daily. This is a critical safety point. Taking methotrexate daily (a common patient error) can cause fatal toxicity. The specific day of the week should be documented clearly, and the pill bottle should be labeled prominently.
• Requires regular blood monitoring. Complete blood count and liver function tests, typically every 4-8 weeks initially, then every 8-12 weeks once stable.
• Folic acid supplementation. Patients on methotrexate must take folic acid (usually 1 mg daily or 5 mg weekly) to reduce side effects like mouth sores and nausea. Missing the folic acid while continuing methotrexate worsens side effects.
• Alcohol restriction. Methotrexate stresses the liver; alcohol makes it worse. The typical guidance is to strictly limit or eliminate alcohol.
• Infection risk. Methotrexate suppresses immune function. What would be a minor cold in a healthy person can become pneumonia in a methotrexate patient.

Leflunomide (Arava) is an alternative to methotrexate. It also suppresses the immune system and requires liver function monitoring. It has a very long half-life, meaning it stays in the body for weeks after the last dose.

Hydroxychloroquine (Plaquenil) is the mildest DMARD and is sometimes used alongside methotrexate. It requires annual eye exams because long-term use can cause retinal toxicity, which is irreversible.

Sulfasalazine is another option, sometimes used in combination with methotrexate and hydroxychloroquine (a combination known as "triple therapy").

Biologic DMARDs

When conventional DMARDs aren't enough, biologic medications are added. These are laboratory-engineered proteins that target specific parts of the immune system:

• TNF inhibitors — adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), certolizumab (Cimzia), golimumab (Simponi)
• IL-6 inhibitors — tocilizumab (Actemra), sarilumab (Kevzara)
• T-cell co-stimulation blockers — abatacept (Orencia)
• B-cell depleting agents — rituximab (Rituxan)
• JAK inhibitors — tofacitinib (Xeljanz), baricitinib (Olumiant), upadacitinib (Rinvoq) — these are oral medications (pills) rather than injections, but they carry similar immune suppression risks

Biologics are highly effective but carry the most significant infection risk of all RA medications.

The infection risk: the caregiver's primary concern

The core challenge of RA medications in elderly patients is this: the drugs that control the disease work by suppressing the immune system, and the immune system is already declining with age. This creates a compounding vulnerability to infection.

What this means practically

• Pneumonia becomes a much more serious threat. An elderly RA patient on methotrexate and a biologic who develops a cough needs medical evaluation sooner, not later.
• Urinary tract infections — common in elderly women — can escalate more quickly to kidney infection or sepsis.
• Shingles risk is elevated. Patients should discuss the Shingrix vaccine with their doctor before starting biologics if possible.
• Tuberculosis — all patients must be screened for latent TB before starting a biologic, because these drugs can reactivate dormant TB.
• Wound healing is slower. A skin tear or surgical wound may take longer to heal, and infection risk is higher.

The "hold" protocol

When an RA patient on immunosuppressive medication develops an acute infection (like a UTI or pneumonia), the standard practice is to temporarily "hold" (stop) the RA medication until the infection resolves. This requires communication between the rheumatologist and the treating doctor. As a caregiver, you may need to initiate that communication, because the urgent care doctor treating a UTI may not know your parent is on a biologic.

Similarly, RA medications are typically held before and after surgical procedures (including dental surgery) to allow normal immune function during healing. The timing varies by drug — some need to be stopped a week before surgery, others longer. This must be coordinated between the rheumatologist and the surgeon.

Side effects caregivers should monitor

For methotrexate

• Mouth sores — common and painful; a sign that folic acid may need adjustment
• Nausea — often worst the day after the weekly dose ("methotrexate hangover")
• Fatigue — the day after dosing is typically the worst
• Liver enzyme elevation — detected on blood tests; may require dose reduction
• Low blood counts — detected on blood tests; increases infection and bleeding risk
• Cough or shortness of breath — rare but serious; methotrexate can cause lung inflammation (pneumonitis)

For biologics

• Injection site reactions — redness, swelling, itching at the injection site
• Infusion reactions — for IV biologics (Remicade, Rituxan), reactions during or after the infusion
• Increased infection frequency — particularly upper respiratory infections
• Reactivation of latent infections — TB, hepatitis B

For JAK inhibitors

The FDA added boxed warnings to JAK inhibitors regarding increased risks of serious heart-related events, cancer, blood clots, and death compared to TNF inhibitors. These warnings are particularly relevant for elderly patients with existing cardiovascular risk factors.

Practical caregiving tips

Create a medication calendar with the weekly rhythm

RA medication schedules are more complex than daily pills. Your parent might take methotrexate on Mondays, folic acid daily except Monday, inject a biologic every two weeks on Fridays, and take prednisone daily at a tapering dose. Mapping this onto a weekly calendar — with clear visual distinction between daily, weekly, and biweekly medications — prevents errors.

Track lab results

Keep a running log of blood test results: complete blood count, liver enzymes, kidney function, inflammatory markers (CRP, ESR). The rheumatologist uses trends in these numbers to adjust treatment. Having the last several results in one place speeds up the appointment and helps you notice concerning patterns.

Keep a symptom and flare diary

Document which joints are affected, morning stiffness duration (a key RA metric), and overall pain level. This helps the doctor assess whether the current medication regimen is working or needs adjustment.

Know the vaccination schedule

RA patients on immunosuppressive medications have specific vaccination requirements and restrictions. Live vaccines (like the older shingles vaccine or MMR) are generally contraindicated while on biologics. Inactivated vaccines (flu, COVID, Shingrix, pneumococcal) are recommended but may produce a weaker immune response. The rheumatologist should provide a vaccination plan.

Communicate across all providers

The rheumatologist prescribes RA medications, but the primary care doctor, cardiologist, or urologist may prescribe other drugs. Many common medications interact with RA drugs (methotrexate + trimethoprim/sulfamethoxazole is a dangerous combination). You are often the only person with the complete medication picture.

Our Medication Management Kit is designed for exactly this kind of multi-provider, multi-medication coordination — with a weekly medication calendar, a lab results tracker, a symptom diary, and a communication sheet you can share with every doctor your parent sees.

The bottom line

Rheumatoid arthritis medication is among the most complex long-term treatment regimens a caregiver will manage. The medications are powerful and effective, but they require consistent monitoring, lab work, infection vigilance, and coordination between specialists. Your parent's RA won't manage itself, and the healthcare system won't coordinate itself. As a caregiver, maintaining the organizational system that keeps treatment safe and effective is one of the most consequential things you can do.